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   Role of Neurogranin in the regulation of calcium binding to Calmodulin 
                                                     Anuja Chandrasekar, B.S 
                                               Advisor: M. Neal Waxham, Ph.D    
The overall goal of my project was to gain a quantitative understanding of how the 
interaction between two proteins neurogranin (RC3) and calmodulin (CaM) alters a fundamental 
property of CaM. CaM, has been extensively studied for more than four decades due to its 
seminal role in almost all biological functions as a calcium signal transducer. Calcium signals in 
cardiac and neuronal cells are exquisitely precise and enable activation of some processes while 
down-regulating others. CaM, with its four calcium binding sites, serves as a central component 
of calcium signaling in these cells. It is aided in this role as a regulatory hub that differentially 
activates targets in response to a calcium flux by proteins that alter its calcium binding 
properties.  
Neurogranin, also known as RC3, is a member of a family of small neuronal IQ (SNIQ) 
domain proteins that was originally thought to play a ‘capacitive’ role by sequestering CaM until 
a calcium influx of sufficient intensity arrived. However, based on earlier work in our lab on 
neurogranin, we believe that this protein plays a more nuanced role in neurons than simply acting 
as a CaM buffer. We believe that neurogranin is one of the proteins which, by altering the 
kinetics of calcium binding allow CaM to decode a variety of signals with fine precision. To 
quantify the interaction between CaM, neurogranin and calcium, I used biophysical techniques 
and computational simulations. From my results, I conclude that neurogranin finely regulates the 
proportion of calcium-saturated CaM and thereby directs CaM’s target specificity.  
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Overview 
I have divided this introduction into two sections. In the general introduction, I have 
attempted to provide a historical overview of CaM and neurogranin, their expression pattern, 
structure and function. In the introduction to concepts, I introduce the reader to fundamental 
principles that underlie the measurements and calculations used in my project and also 
provide a larger context of the biological significance of these proteins and the need to study 
them in such detail.  
Section 1: General Introduction 
1.1 Calmodulin (CaM) 
1.1.1 CaM-Historical Perspective 
Calmodulin (CaM) is the best-studied prototype of the EF-hand family of calcium 
sensing proteins. It is a 148 amino acid protein that was first discovered in brain and heart as 
an activator of cyclic nucleotide phosphodiesterase and isolated using a gel filtration column 
((Kakiuchi et al. 1975),(J. H. Wang et al. 1975), (Teo and Wang 1973),(Cheung 1970)). This 
cytosolic protein is the primary calcium sensor in almost every cell in every eukaryotic 
organism studied. The functions of CaM are diverse ranging from regulation of various 
stages of the cell cycle to transcriptional regulation in the nucleus to regulation of synaptic 
plasticity in neurons.  
In neurons, CaM interacts with kinases like calcium/CaM dependent protein kinase I, 
II and IV (CaMK I,II and IV), the phosphatase calcineurin, small neuronal IQ domain 
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proteins (SNIQ) proteins like neuromodulin, neurogranin, PEP-19, enzymes like nitric oxide 
synthase and ion channels like L-type calcium channels, sodium channels, potassium 
channels to name a few (Prichard, Deloulme, and Storm 1999,Peterson et al. 1999, Kim et 
al. 2004, Putkey et al. 2003, Zhang et al. 1994, Mulkey et al. 1994). Interestingly, many of 
these CaM binding proteins like neuromodulin, neurogranin, PEP-19, L-type calcium 
channels and sodium channels have an IQ domain through which they interact with CaM. 
This raises the interesting possibility that studying IQ domain proteins might provide 
valuable insights into regulation of CaM and help answer fundamental questions of calcium 
metabolism in the brain. 
 1.1.2 CaM expression  
 The vertebrate CaM family is a unique example of genetic redundancy where 
multiple non-allelic genes encode the identical protein and not isoforms of each other. CaM 
is a highly conserved protein and is encoded by three different genes in mammals, CaM I, II 
and III (Nojima 1989). All three CaM genes are expressed in neurons and their levels of 
expression are differentially regulated (Gannon and McEwen 1994). For example 
administration of NMDA antagonist AP-5 to rats resulted in specific reduction of CaM I 
mRNA in the caudal colliculus at postnatal day 10 (Berry, Prusky, and Brown 
1996).Treatment of adult mice with kainate led to an increase in CaM I mRNA, a decrease 
in CaM II mRNA and no change in CaM III expression (Michelhaugh, Pimputkar, and 
Gnegy 1998). CaM expression is likely strictly regulated in neurons because of its 
involvement in a variety of neuronal functions. The redundancy of genes encoding the 
identical protein (unique to CaM) and the strict regulation of CaM translation indicate that 
there are multiple regulatory levels to ensure accurate CaM expression. This tight regulation 
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of CaM protein expression is evidence of the importance of this protein in biologic 
processes.  
1.2 Structure of CaM 
1.2.1 Crystal structure 
The crystal structure of CaM was first determined at 3A° resolution (Babu et al. 
1985) and subsequently at 3.6A° by (Kretsinger, Rudnick, and Weissman 1986).  The 
structure was further refined at 2.2 A°and 1.7 A° by two different groups (Babu, Bugg, and 
Cook 1988, Chattopadhyaya et al. 1992). The CaM structure is dumbbell shaped, with an 
overall length of 65 A°. Each lobe is 25x20x20 A° and connected by an eight-turn α-helix. 
Each CaM molecule has two EF hand domains (calcium-binding loops) arranged in a 
globular N-terminal domain followed by a central helix linker and two EF hand domains 
arranged in a globular C-terminal domain. Adjacent calcium-binding loops are separated by 
double-stranded antiparallel beta-sheets. The N-terminal globular domain has a lower 
affinity of calcium binding and a faster off-rate and on-rate. The C-terminal globular domain 
has a higher affinity towards calcium and slower off-rate and on-rate. Upon binding calcium, 
CaM is activated and in turn recognizes protein targets.   
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Figure 1.1: Crystal structure of apoCaM and calcium/CaM 
 
 
Crystal structure of apoCaM (left) and calcium/CaM (right).Calcium binds to the two   
EF hand loops in the N-terminal lobe and C-terminal lobe. The region at the center  
of the helix (unwound in apo-CaM) is believed to undergo changes in solution and  
upon binding to targets. 
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1.2.2 Solution structure 
The solution structure of CaM was studied in 1988 by Heidorn and Trewhella 
(Heidorn and Trewhella, 1988).  They concluded based on modeling studies and X-ray 
solution scattering data that there is a difference between the crystal structure and the 
solution structure and that the solution structure involves considerable structural changes in 
the helix connecting the globular domains. Furthermore, structural changes upon target 
binding to CaM in solution was studied by Ikura and colleagues (Ikura et al. 1992). This 
group studied calcium ligated CaM complexed with skMLCK peptide. They discovered that 
the residues aspartate 78 through serine 81 which are located in the middle of the ‘central 
helix’ of CaM forms a very flexible link between globular domains. They concluded that the 
helical skMLCK peptide is located in a hydrophobic channel going through the center of the 
complex and makes an angle of ~45° with the long axis of the complex.  
1.2.3 Association of CaM’s structural flexibility and calcium transduction functions  
A fascinating aspect of CaM biochemistry is its ability to respond to calcium signals 
of different frequency and amplitude and activate different targets. A study of the structure 
of CaM shows that this remarkable function might be tied to its structural flexibility. 
Multidimensional heteronuclear nuclear magnetic resonance spectroscopy of structure of C-
terminal of CaM in solution indicated major rearrangements within the secondary structure 
elements with changes in inter-residue distances of up to 15 A°. This structural 
rearrangement within each globular domain results in exposure of the hydrophobic residues 
within a methionine-rich crevice in each domain that is distinct from the calcium binding 
loop. The exposure of hydrophobic residues to solvent is equivalent to a calcium-controlled 
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unfolding of CaM and releases free energy. It is this ability to convert a biochemical event 
into free energy that forms the basis of CaM’s ability to transduce calcium signals (Finn et 
al. 1995).  
1.3 Functions of CaM 
CaM through its ability to bind to calcium ions regulates a number of important 
biological functions like cell growth, gene expression, cell motility, protein 
phosphorylation-dephosphorylation cascades, ion transport, calcium transport, 
cytoskeletal function and neurotransmitter and  hormone action to name a few ((Youn et 
al. 1999; Rasmussen and Means 1989; Hinrichsen and Blackshear 1993)).  
1.3.1 Role of CaM in long-term potentiation in neurons 
CaM plays an active role in regulating a plethora of diverse and important 
neuronal functions. Perhaps, the best characterized and the most well-studied function of 
CaM in neurons is its role in long-term potentiation and long-term depression.  
Long-term potentiation was first described by Bliss and Lomo in the 
hippocampal formation (Bliss and Lomo 1973). When a synapse is repeatedly 
stimulated, transmission of signal between the two neurons at that synapse is 
strengthened. One of the reasons for strengthening is believed to be recruitment of 
additional neurotransmitter receptors at the synapse as well as modifications to the 
synaptic receptors which increase ion influx through them. Calcium/CaM activates the 
multifunctional protein CaMKII. At resting calcium, CaMKII is auto-inhibited. When 
calcium
 
rises, binding of Ca
2+
/CaM to CaMKII relieves inhibition and the activated 
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CaMKII phosphorylates AMPA receptors as well as other targets which play a role in 
long-term potentiation (Malenka, R.C. et al.,1989; Malinow, R et al., 1989)  
 
1.3.2 CaM and long-term depression in neurons 
While CaM responds to high calcium influx by activating CaMKII, in response 
to low calcium
 
influx, CaM activates calcineurin. Long-term depression is a reduction in 
strength of synaptic transmission following constant,low frequency stimulation that was 
first reported in cerebellar cortex by Ito and Kano(Ito and Kano 1982). Calcineurin is a 
calcium-dependent serine-threonine phosphatase that has been implicated in long-term 
depression. This protein is activated by CaM whereupon it dephosphorylates and 
inactivates inhibitor-1 which in turn increases protein phosphatase 1 and contributes to 
long-term depression(Mulkey et al. 1994) 
 
1.3.3 CaM involvement in hippocampal long-long term potentiation 
 In the hippocampus, long-long term potentiation (L-LTP), a type of long-term 
potentiation at the CA1-schaffer collateral synapse is dependent on de novo transcription 
and translation. CaM is not the primary molecular player involved in L-LTP but acts 
through activation of proteins involved in L-LTP. Activity dependent translation at the 
synapse is initiated by activated cAMP responsive element binding protein (CREB)  
(Barco, Alarcon, and Kandel 2002).CREB is activated by phosphorylation by three main 
enzymes - ERK/MAPK, adenylyl cyclase and CaMKIV –all of which are regulated by 
CaM.  
 
9 
 
1.3.4 CaM’s role in regulation of calcium influx into neurons 
CaM, besides regulating calcium dynamics within the neuron leading to long-
term potentiation and long-term depression also controls calcium influx into the neuron. 
It performs this role by binding constitutively to some channel proteins through IQ-like 
motifs present in the intracellular domains of these channels.  
For instance, CaM was found to be crucial for calcium-dependent inactivation of  
L-type calcium channel (LTCC). Expression of mutants of CaM (CaM (3-)) incapable of 
binding calcium resulted in loss of calcium-dependent inactivation (Zühlke et al. 1999). 
The importance of CaM for calcium-dependent inactivation was further reinforced by 
David Yue and colleagues when they overexpressed calcium-insensitive CaM and found 
that this ablated calcium-dependent inactivation in a “dominant negative” manner 
(Peterson et al. 1999). CaM was  also found to be important for functional expression of 
some isotypes of voltage gated sodium channels (Nav1.4 and Nav1.6), and impacted the 
inactivation kinetics and the current density through the channel (Herzog et al. 2003) . 
Both these channels regulate calcium influx into neurons. 
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Table 1.1: Examples of CaM-activated proteins that regulate a variety of biological   
functions 
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1.4 Post translational modifications of CaM and its effect on target 
binding capabilities of CaM  
There has been significant research on the post-translational modifications of CaM 
targets and the functional implications on CaM-target recognition. Following are examples 
of post-translational modifications of CaM and their functional implication. 
1.4.1 Methylation  
CaM is methylated at lysine 115 in higher organisms. However, the functional 
implication of methylation is still unclear as unmethylated CaM can activate most known 
target proteins except NAD kinase which is more sensitive to activation by unmethylated 
CaM (S.-H. Oh and Roberts 1990; S. H. Oh et al. 1992; Bitensky 1988).  
1.4.2 Glycation 
Glycation of lysine side chains of CaM reduces CaM’s ability to bind to calcium and 
activate target enzymes. Although glyco-CaM is not normally found, it has been isolated 
from diabetic individuals and maybe involved in the histopathological development of the 
disease(Kowluru et al. 1989).  
1.4.3 Phosphorylation 
CaM is phosphorylated at multiple sites. Phosphorylation has specific effects on 
target activation and hence represents a mechanism by which CaM differentially regulates 
targets within a cell. Phosphorylation of CaM by Casein Kinase II reduced the binding 
affinity of CaM for PDE without changing the activation kinetics(Sacks et al. 1992). 
Phosphorylation at tyrosine 99 generated a form of CaM that more effectively activated PDE 
and had a greater affinity for this target than the wild-type CaM.  
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1.5 Small neuronal IQ (SNIQ) domain proteins- a target of CaM 
 Small neuronal IQ domain proteins also known as calpacitins are a family of 
proteins that have an IQ domain through which they interact with CaM. The name 
‘calpacitin’ was based on the observation that members of this protein family act like 
capacitors, binding to CaM at resting conditions and releasing it slowly or rapidly depending 
on the amplitude and frequency of calcium flux (Gerendasy and Sutcliffe 1997; Gerendasy 
et al. 1994).These proteins are characterized by their sequence homology in and around their 
CaM-binding domain, high concentrations within specific regions of the neuron as well as 
their ability to interact with calcium-free and calcium
 
-bound forms of CaM in a regulated 
manner allow these proteins to regulate the calcium binding kinetics of enzymes that require 
Ca
2+
/CaM.  
 
1.5.1 Members of SNIQ domain protein family 
The well-studied  members of  the family of SNIQ domain proteins are PEP-19 also 
known as Pcp 4, GAP-43 also known as neuromodulin and RC3 also known as neurogranin. 
Two of these proteins are relatively small in size. PEP-19 is a 61-amino acid polypeptide 
and neurogranin is 78-amino acid long. Neuromodulin is a slightly larger protein that is 239 
amino acids long. With the exception of PEP-19 interactions between CaM and each of the 
calpacitins can be regulated by post-translational modifications. For example, neurogranin 
and neuromodulin contain a serine residue within their CaM-binding domain that can be 
phosphorylated and whose phosphorylation abrogates CaM binding to these proteins(Huang 
et al. 2004). In addition, nitric-oxide induced oxidation of neurogranin has been shown to 
attenuate its affinity for CaM (Li et al. 1999; Mahoney, Pak, and Huang 1996; Sheu et al. 
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1996).This results in additional regulatory mechanisms that can finetune CaM-calcium 
interaction. The post-translational modifications of neurogranin are described in detail in the 
next section where I use it in discussing the biological significance of neurogranin. 
 
1.5.2 Expression patterns of SNIQ proteins 
Neuromodulin is predominantly expressed in the neocortex, areas CA1 and CA3 of 
the hippocampus, subcortical nuclei such as the locus coeruleus, inferior olivary nucleus and 
part of the thalamus and hypothalamus(Benowitz et al. 1988; McNamara and Lenox 1997; 
Kruger et al. 1993). Neurogranin is expressed in the cortex, hippocampus and striatum with 
lower levels of expression in the olfactory bulb and midbrain and no expression in the 
cerebellum(Watson, Szijan, and Coulter 1994). PEP-19 is expressed in several regions of the 
nervous system including the cortex, putamen, olfactory bulb, retina, substantia nigra, 
hippocampus and dorsal-root ganglion(Ge,X.,et al 2005;Karl Skold, M.S., et al 2006) 
1.5.3 Role of SNIQ proteins in neurons 
The function of small neuronal IQ (SNIQ) domain proteins in neurons is of interest 
because of the high concentrations of these proteins in neurons (Ziai et al. 1986, Prichard, 
Deloulme, and Storm 1999). In fact, many members of this protein family were first isolated 
from various regions of the brain. PEP-19 was first discovered in functional genomics 
studies that aimed to identify markers of cerebellar development. One of the ways 
neurogranin was discovered was using a subtractive hybridization screen that aimed to 
identify proteins expressed in the cortex but not in the cerebellum(Prichard, Deloulme, and 
Storm 1999). Neuromodulin was discovered as a protein whose phosphorylation increased 
during the induction of synaptic plasticity(Akers and Routtenberg 1985).  
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a) PEP-19: PEP-19 expression in the cerebellum is widely considered to serve a 
protective function in Alzheimer’s Disease (AD). The primary afferent neurons in 
the cerebellum are the purkinje cells where PEP-19 expression is at a high-level. 
These cells are mostly spared from the disease. However, PEP-19 negative 
pyramidal cells that are downstream of the granule cells in the dentate gyrus show 
considerable loss of neurons in Alzheimers disease(Slemmon et al. 1994). In 
Huntington’s Disease, the mutant huntingtin protein demonstrates an increase in 
affinity to CaM when compared to the wild-type huntingtin protein. This could 
potentially result in regulation of calcium homeostasis through altered interaction 
with CaM. Furthermore, structures affected in huntington’s disease including caudate 
nucleus, putamen, globus pallidus ,and substantia nigra show a large loss in PEP-19 
expression (Utal et al. 1998). It is possible that PEP-19 loss accelerates the process 
by which calcium homeostasis is lost in huntington’s disease.  
b) Neuromodulin: Neuromodulin is a SNIQ domain protein concentrated in the growth 
cones of presynaptic neurons. This localization suggests that it is involved in axon 
elongation or in synapse organization and reformation. In toad retinal ganglion cells, 
neuromodulin synthesis began approximately four days after axotomy and the rise in 
neuromodulin production coincided with or slightly preceded initiation of axon 
outgrowth. Further evidence that neuromodulin might contribute to growth cone 
activity by regulating cell membrane structure came from experiments in CHO, COS 
and NIH 3T3 cells. Expression of neuromodulin in these cells resulted in the 
induction of filopodium-like structures projecting from the cytoplasmic membranes 
of these non-neuronal cell lines. (Liu and Storm 1990)proposed a biochemical model 
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where neuromodulin sequesters CaM at membrane tips. Phosphorylation of 
neuromodulin at its critical CaM binding domain by protein kinase C would release 
high concentrations of CaM locally in the growth cones. The release CaM interacts 
and affects the polymerization and crosslinking of polymers like actin and spectrin 
resulting in growth cone elongation. Thus various SNIQ domain proteins, through 
their interaction with CaM play an important role in neurons. 
1.6 Neurogranin- a SNIQ protein 
1.6.1 Historical perspective  
Neurogranin, named because of its granular appearance in immuno-
cytochemical studies, was first discovered in a subtractive hybridization screen 
looking for mRNAs expressed in the forebrain but not the cerebellum (Watson et al. 
1990).  The protein was termed RC3 for rodent cortex enriched clone #3. It was 
isolated a second time from bovine brain as a perchloric acid soluble substrate of 
protein kinase C and called p17 based on the apparent molecular weight of the 
protein on SDS gels(Baudier et al. 1991). It was discovered a third time based on its 
cross-reactivity to neuromodulin antibodies and was called B-50 immunoreactive C-
kinase substrate (BICKS)(Coggins and Zwiers 1990).  
Sequencing of neurogranin revealed that the protein sequence shared many 
homologous regions with neuromodulin. Neurogranin and neuromodulin show a 
high degree of homology around the IQ domain as well as in their N-termini. The 
homologous regions in neurogranin and neuromodulin includes the serine 
phosphorylation site and a peptide sequence that forms an efficient and specific PKC 
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substrate (the IQ motif). The region around the IQ motif with is involved in CaM 
binding and membrane-PKC interactions. 
Figure 1.2: Multiple protein sequence alignment of RC3 and GAP-43 sequences 
from rat, cow and humans 
 
1.6.2 Genetics of neurogranin: Encoding genes 
              The rat neurogranin cDNA isolated through subtractive hybridization encoded a 78 
amino acid sequence product. Using antisera raised against peptides from two different 
regions of the translated product, neurogranin protein was detected in the forebrain by 
immunocytochemistry. The mouse homolog was then cloned and used to map the gene to 
the proximal region of chromosome 9(Danielson et al. 1994). The locus was designated Pss1 
for post synaptic spine 1. The human neurogranin gene was mapped to chromosome 11q24 
which is syntenic with the mouse locus Pss1. Northern blots of rat and mouse forebrain 
revealed mRNAs of two lengths 1.0 kb and 1.4 kb(Watson et al. 1990). 
 The human and rat genes have four exons and three introns. The first exon codes the 
5’ untranslated region (UTR) and the first five residues of the protein. The second exon 
encodes the bulk of the protein (73 residues) and a part of the 3’ UTR while the third exon 
contains an 18 base pair portion of the 3’ UTR. The fourth exon, which has only 70% 
homology between rat and humans contains the rest of the 3’ UTR and the polyadenylation 
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signal. The first intron is long, about 5.5 kb in human, while the second and third introns are 
233 bp and 408 bp respectively, in human. 
1.6.3 Expression pattern of neurogranin 
The mRNA is abundant in various thalamic and hypothalamic nuclei, several regions 
of the olfactory bulb and tubercle, the medial amygdaloid nucleus and pontine nucleus as 
well as in the caudate putamen, the CA1 and CA3 regions of the hippocampus, the dentate 
gyrus, the primary olfactory cortex, the somatomotor cortex and the frontal cortex. The 
protein expression is more restricted and is abundant in the frontal parietal cortex, granular 
cells of the dentate gyrus, apical dendrites of pyramidal cells of the CA1 and CA3 regions of 
the hippocampus and in the striatal cortex. 
The peak expression of the protein occurs between post natal day 14 and post natal 
day 20 (Alvarez-Bolado et al. 1996; Represa et al. 1990) which is the period during which 
more than 80% of cortical synapses are formed. Interestingly, an increase in neurogranin 
expression coincides with the onset of synaptogenesis in rats and mice and its expression 
occurs in those regions of the brain that exhibit a high degree of neuroplasticity ((Hashimoto 
et al. 1988; Sposi et al. 1989)providing a developmental neurobiology argument for 
neurogranin’s contribution to neuroplasticity. 
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Section 2: Introduction to concepts 
1.7 Thermodynamic principles used in study 
1.7.1 Free energy of coupling  
When two molecules interact, there is a change in free energy. In 1982, 
David Storm’s group at University of Washington, investigated this change in free 
energy for the interaction between calcium, CaM and a CaM-binding protein 
troponin I using fluorescence measurements and equilibrium dialysis. The aim was 
to characterize the binding of calcium
 
to CaM in the presence of CaM-binding 
protein. The data obtained from the experiments was analyzed using the method 
proposed by Weber(Weber 1975).   
Figure 1.3: Scheme for interaction between CaM and troponin-I        
 
In the scheme, TnI refers to Troponin I, ∆G°(C) refers to the free energy change 
upon binding of 1 mol of calcium to CaM , ∆G°(I) stands for the free energy change upon 
binding of TnI to CaM, ∆G°(C/I) is the free energy change upon binding of 1 mol of 
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calcium to the CaM-TnI complex and ∆G°(I/C4) is the free energy change upon binding of 
TnI to fully saturated CaM. 
Conservation of free energy requires 
4[∆G°(C/I) - ∆G°(C)] = ∆G°(I/C4) - ∆G°(I) = 4∆G°IC  
 
where ∆G°IC is the average free energy of coupling for binding of 1 mol of calcium and 
troponin I to CaM . Based on calculations of ∆G from experimentally measured Kd , it was 
estimated that the affinity of troponin I for CaM is increased 4500 fold when CaM is 
saturated with calcium. This concept of free energy and calculation of free energy from 
dissociation constants is important for this dissertation because I have used these concepts in 
evaluating the quantitative interactions of neurogranin with CaM in the absence and 
presence of calcium. 
1.7.2 Conservation of free energy  
Another thermodynamic principle of importance in my work is the idea that the free 
energy of binding (ΔG) of a chain of binding reactions should be the same regardless of the 
order of binding. Illustrated below is a scheme of binding of calcium and target to CaM. The 
free energy to go from apo-CaM to target-bound fully saturated CaM is the same 
irrespective of whether calcium binds first or the target binds first.        
Using the example below, 
ΔG1+ ΔG2+ ΔG7= ΔG5+ ΔG12+ ΔG11 
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Since, 
ΔG= -RT ln(Kd) 
Kd1*Kd2*Kd7 = Kd5*Kd12*Kd11 
Keq1*Keq2*Keq7 = Keq5*Keq12*Keq11 
If Keq11 is higher than Keq1, Keq2*Keq7 should be higher than Keq5* Keq12  to maintain equality. 
Since Keq is a measure of affinity of interaction, the implication is that if a target binds to 
calcium/CaM with higher affinity, the probability of target bound CaM remaining fully 
saturated with calcium is higher. 
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 Figure 1.4: Illustration of the principle of conservation of free energy 
 
   
(Brown and Bertolet, 1997) 
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1.8 Kinetics of calcium binding to CaM 
The versatility and tenability of CaM has spawned interest in the kinetics of calcium 
binding for decades. Multiple groups have studied the kinetics of calcium binding to CaM 
under different experimental conditions and using fragments of CaM as well as the whole 
molecule.  
Peter Bayley and colleagues used stopped flow fluorescence to measure calcium 
dissociation rates from the N-terminal and C-terminal lobes of CaM . They determined the 
rate of calcium dissociation from the N-terminal lobe to be 293 to 550 s
-1 
for a temperature 
range of 11 to 19⁰C. The rate of calcium dissociation from the C-terminal lobe was 
determined to be 2 to 9 s
-1 
for a temperature range of 11 to 28⁰C.  
In order to determine calcium dissociation rates of individual binding sites, Linse and 
co-workers used tryptic fragments to measure calcium dissociation rates from fragments 
which contained only the N-terminal domain calcium binding sites or C-terminal calcium 
binding sites. They determined that the macroscopic binding constants of the tryptic 
fragments are identical to the sites in intact CaM (K
D1
=12.6 μM, K
D2
=0.25μM in the C-
terminal lobe, and K
D3
=40 μM, K
D4
=2.5 μM in the N-terminal lobe). Putkey and colleagues 
reported values for equilibrium constants of calcium binding which were very similar to 
those reported by Linse and colleagues (Putkey et al., 2008). 
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1.9 Significance of studying calcium transduction by CaM 
The calcium binding properties of CaM have been of interest to researchers for 
decades. The three main factors that make CaM such a key molecular player in calcium 
signal transduction are its abundance and ubiquitous presence, its versatility as a calcium 
sensor and its tunability by targets. 
CaM is ubiquitously and abundantly present in many cells and plays a critical role in 
regulating the biological function of these cells. For example, in the central nervous system 
CaM is present in extremely high concentrations (from 10 to 100 uM in different areas of 
the brain (Cimler et al. 1985) and transduces calcium signals following an action potential.  
The four calcium binding sites of CaM bind calcium with different affinities and 
different rates of binding. This property allows CaM to act as a versatile calcium sensor that 
can transduce calcium signals of different frequency and amplitude (Bayley et al. 1984; 
Teleman, Drakenberg, and Forsén 1986; Linse, Helmersson, and Forsén 1991). 
 Finally, there are more than 300 targets of CaM that have been identified. Many of 
these targets of CaM interact with it reciprocally and alter the affinities and rates of calcium 
binding making CaM a tunable calcium sensor. 
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1.10 Quantification of reciprocal effect of targets on CaM 
The ratio of CaM targets to CaM has been estimated to be 2:1 by some 
groups(Slemmon and Martzen 1994; Slemmon and Flood 1992; Slemmon et al. 1996). From 
a mass action standard point, this estimate of concentration ratios makes the regulation of 
CaM by its targets a very attractive hypothesis. Quantitation of the interaction between CaM 
and its targets provides good insights into the regulation of CaM’s properties by its targets. 
Explained below are two examples of methods by which CaM’s interaction with targets and 
the reciprocal effect of targets on CaM’s calcium interaction have been accurately quantified 
using quantitative experimental techniques.   
Olwin and colleagues determined free energies of coupling for the interaction of 
calcium and myosin light chain kinase with CaM by micro-equilibrium dialysis using 
45
CaCl2 and by fluorescence anisotropy using fluorescent labeled CaM (Olwin et al., 1984). 
The mean dissociation constants for calcium interaction with CaM in the presence and 
absence of enzyme were 0.40 and 14 µM, respectively, yielding a minimal estimate for free 
energy of coupling of -2.11 kcal/mol of Ca
2+
 (-8.44 kcal/4 mol of Ca
2+
). The free energy 
coupling for binding of myosin light chain kinase to CaM and substrates was -0.95 kcal/mol 
of CaM. From this data, the interpretation was that in the presence of myosin light chain 
kinase interaction of calcium with CaM was a highly ‘cooperative’ process.  
Another example where equilibrium and kinetic constants were used to determine 
interaction of CaM and its targets was the study of CaM interaction with endothelial nitric 
oxide synthase and a fluorescent myosin light chain kinase (MLCK) analog. The Kd and Kon 
of nitric oxide synthase for Ca
2+
/CaM are 0.2 nM and 1.5 x 10
5
 M
-1
s
-1 
which are 10 and 100 
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fold smaller than the values for the MLCK analog. Thus, even though the target MLCK 
analog binds CaM quickly due to its high association rate constant, it dissociates quickly 
from CaM as well due to the high dissociation rate. At equilibrium, a greater percentage of 
CaM is expected to bind to nitric oxide synthase since it has a higher affinity to CaM. As 
expected, when calcium
  
was added to a mixture of CaM, target analog and synthase in vitro, 
a large fluorescent transient corresponding to a rapid binding of analog to calcium/CaM 
followed by a slower capture of calcium/CaM by higher affinity synthase was seen.  
1.11 Neurogranin as a CaM target 
Neurogranin was discovered as a protein kinase C (PKC) substrate isolated from 
mouse hippocampi. The biochemical properties of neurogranin like its ability to regulate 
CaM-dependent nitric oxide synthase, its interaction with membrane phospholipids and its 
phosphorylation by PKC implicated it in several signaling pathways(Martzen and Slemmon 
1995; Slemmon and Martzen 1994; Lu and Chen 1997; Paudel, Zwiers, and Wang 1993). 
However, the physiological functions of neurogranin was unclear. Storm and colleagues 
utilized yeast two-hybrid technology to detect neurogranin-binding proteins in 
vivo(Prichard, Deloulme, and Storm 1999). They determined that the only protein that 
neurogranin interacted with in vivo was CaM. Detailed biochemical studies on neurogranin 
by Gerendasy and group led them to suggest that neurogranin had a non-linear response to 
calcium, releasing CaM rapidly in response to a large calcium influx and slowly in response 
to small increases analogous to the behavior of a capacitor. However, systematic studies on 
the interaction between neurogranin and CaM using stopped flow fluorimetry and 
fluorescence anisotropy suggested that neurogranin also tunes CaM’s calcium binding 
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properties. Furthermore, post-translational modification of neurogranin tuned neurogranin’s 
ability to interact with CaM.  
These properties of neurogranin led our group to quantify the interaction between 
neurogranin and CaM. 
1.12 Post-translational modifications of neurogranin  
1.12.1 Phosphorylation and de-phosphorylation of neurogranin 
The primary amino acid sequence of neurogranin has some highly conserved 
residues which are homologous to a region near the amino acid terminus of GAP-43. This 
conserved stretch of residues contains the site of phosphorylation by protein kinase C 
(Baudier et al. 1991) which is a serine at position 36. The ability of neurogranin to be 
phosphorylated is critical for its role in long-term potentiation(Ramakers et al. 1995). 
Phosphorylation of RC3 interferes with its binding to CaM. Conversely, interaction of CaM 
with RC3 can inhibit phosphorylation by PKC, presumably by blocking access of the kinase 
to serine 36. Neurogranin, by virtue of being a PKC substrate is ideally situated to be at the 
intersection of the two signaling pathways from the metabotropic and glutamergic receptor 
pathways.  
Neurogranin is dephosphorylated in vitro by calcineurin and protein phosphatases 1 
and 2A (Seki et al., 1995). This raises the interesting possibility that neurogranin, like CaM 
is subjected to the influence of both kinases and phosphatases and the amount of activated 
neurogranin might be finely controlled by the balance between activation by 
phosphorylation and inactivation by dephosphorylation. 
27 
 
1.12.2 Other post-translational modifications of neurogranin 
Nitric oxide causes oxidation of neurogranin in rats. Neurogranin has four cysteine 
residues at positions 3, 4, 9 and 51.  Systematic replacement of each of the cysteine residues 
individually or in combinations with serine and glycine and examination of the intra 
molecular disulfide bonds formed indicated that cysteine 51 forms a disulfide bond that is 
induced by oxidants(Mahoney, Pak, and Huang 1996). The disulfide bond between cysteine 
51 and any of the other cysteine residues at positions 3, 4 or 9 presumably alters the 
conformation of the PKC-recognition/CaM-binding domain that lies between Cys51 and the 
other three cysteine residues. 
 Neurogranin was found to bind selectively to phosphatidic acid when lipid-protein 
overlay assays were done using PIP strips. Furthermore, interaction of neurogranin and 
phosphatidic acid is prevented by CaM and inhibited by PKC phosphorylation of the serine 
residue in the IQ domain. This is an interesting result because phosphatidic acid is a 
membrane lipid and it is believed that interaction with this lipid might serve to localize 
neurogranin to membranes. Phosphorylation might thus serve to disrupt membrane 
localization of neurogranin apart from interfering with its interaction with CaM. 
1.13 Neurogranin and synaptic plasticity  
 LTP induction in hippocampal extracts when led to an observed increase in post hoc 
phosphorylation of a 17 KDa PKC substrate which was later named neurogranin(Klann, 
Chen, and Sweatt 1992; Klann, Chen, and Sweatt 1993). Long term potentiation (LTP) is a 
phenomenon where when a synapse is repeatedly stimulated, transmission of signal between 
the two neurons at that synapse is strengthened. The findings in hippocampus were 
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consistent with other in situ phosphorylation studies that demonstrated neurogranin 
phosphorylation when LTP was induced(Gianotti et al. 1992; Ramakers et al. 1995).   
Neurogranin’s role in LTP was further demonstrated in experiments conducted by 
Fedorov and colleagues in which a monoclonal antibody introduced against the CaM 
binding/PKC recognition domain of neurogranin in hippocampal CA1 region blocked 
LTP(Fedorov et al. 1995). Quantitative immuno-precipitation of neurogranin 10,30, 60 and 
120 minutes after LTP induction lead to the observation that there was a 78% increase in 
phosphorylation only at the 60 min time-point(Ramakers et al. 1995). Phosphorylation was 
NMDA-dependent and did not occur in those slices that failed to produce LTP.  
1.14 Neurogranin knock-out mice 
 Neurogranin knock-out mice were generated by Gerendasy and colleagues and 
Huang and colleagues. In both cases, neurogranin was knocked-out by homologous 
recombination. These mice did not show any gross developmental or neuroanatomical 
abnormality. Studies in neurogranin knock-out mice revealed that calcium influx through 
NMDA receptor was lower in the case of neurogranin knockout mice compared to wildtype 
mice(van Dalen et al. 2003). Lowered calcium influx could result in reduced activation of 
calcium dependent proteins that are required for LTP.  Furthermore, in another study, 
neurogranin knockout mice showed deficiencies in hippocampal short and long-term 
plasticity as seen by their performance in the morris water maze test, an assay to test spatial 
memory. These mice also displayed decreased basal level of activated calcium/CaM kinase 
II which is a protein crucial for induction of LTP    (CaMKII in knock-out mice ~ 60% of 
wildtype mice)(Pak et al. 2000).   
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Interestingly, the knockout mice from Gerendasy and group showed an enhancement 
in LTP induction and a reduction in LTD induction. These results seem to be contradictory 
to the results published by Pak and colleagues. Thus, knocking out neurogranin seems to 
affect the degree of synaptic potentiation which is likely due to the regulation of CaM by 
neurogranin.                      
1.15 Crystal structure of neurogranin bound to CaM 
In March 2013, the crystal structure of a region of neurogranin bound to CaM was 
determined by Gerges and group(Kumar et al. 2013). This was the first successful attempt at 
crystallization of a region of neurogranin. Initial attempts at crystallizing the full protein 
were unsuccessful because neurogranin is an intrinsically disordered and unstructured 
protein that is not amenable to crystallization. Hence, Gerges and colleagues used a shorter 
peptide sequence of neurogranin containing mostly the CaM binding IQ domain and a few 
amino acids outside of the IQ domain, RC3(27-50). They linked this peptide to the C-lobe of 
CaM using a 5 glycine linker and crystallized this CaM- bound structure. 
The crystal structure of RC3(27-50) showed that the neurogranin peptide adopted an 
α-helical structure that was almost perpendicular to the central α-helix of CaM, making 
several contacts with the C-lobe and a few contacts with the central helix of CaM. The 
amino acid residues within the IQ region that interact with CaM significantly are Ile33, 
Ser36 and Arg38. Serine 36 phosphorylation disrupts binding to CaM and phosphatidic acid. 
This residue of neurogranin in the crystal structure was buried in a pocket surrounded by 
negatively charged residues of CaM. Phosphorylation of the serine residue likely repels the 
negative charges in the pocket weakening binding to CaM. Arginine residue which is highly 
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conserved and is another residue which was found to form contacts with CaM might have an 
essential role in mediating the interaction of IQ motif with CaM. A mutation of this residue 
to glutamine reduced the binding strength of neurogranin to CaM. 
In summary, the first reported crystal structure of the intrinsically disordered protein 
neurogranin in complex with CaM provides a structural basis for the interaction of 
neurogranin with CaM, a crucial association for several learning and memory-associated 
functions in neurons. 
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            Figure 1.5: RC3 peptide interaction with the C-lobe of CaM 
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CHAPTER 2 
MATERIALS AND 
METHODS 
 
 
 
 
 
 
 
 
 
 
33 
 
2.1 Isothermal Titration Calorimetry (ITC) 
 Isothermal titration calorimetry (ITC) is a technique that measures the 
endothermic/exothermic change when molecules interact. The ITC machine used to make 
measurements is the VP-ITC machine from microcal (GE healthcare systems). The 
experiment consists of injection of a small volume of one sample containing one of the 
interacting molecules into a sample cell containing a solution of the other molecule. There is 
also a reference cell filled with water/buffer in which the solutions are made. Each injection 
occurs over a fixed time period with a fixed time interval between consecutive injections. 
The readout from the ITC machine is the difference in temperature between the reference 
and sample cell calibrated to power units. The area under the curve for each injection is 
integrated and the resulting data points are fit using a binding curve from which the 
dissociation constant Kd is calculated.  
Most of the ITC experiments were carried out at 25°C and a few experiments were 
carried out at 37°C. In the case of neurogranin peptides, the peptides are present at a 
concentration of 150 µM in a buffer solution of 25 mM HEPES or a solution containing 25 
mM HEPES and 150 mM KCl in the syringe. The sample cell contains the protein at a 
concentration of 10 µM in a buffer solution of 25 mM HEPES or a solution containing 25 
mM HEPES and 150 mM KCl. Each injection occurs over a duration of 5 seconds and the 
time interval between injections is 20 seconds. The reference cell is maintained at the same 
temperature at which the experiment is run by providing constant power to the reference 
cell. The data obtained from the ITC experiments are analysed using a software from 
microcal. 
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2.2 Stopped flow fluorescence 
 All stopped flow experiments were performed using the Applied Photophysics Ltd 
(Leatherhead, UK) model SV.17 MV machine with a dead time of 1.7 ms. Stopped flow 
fluorescence experiments were performed to determine calcium (Ca
2+
) binding to CaM in 
the presence/absence of neurogranin peptides. Two different experiments were performed to 
study calcium binding.   
a) Quin-2 experiments: The Quin-2 experiments were performed as described 
in(Putkey et al. 2003). CaM and the neurogranin peptides were made up in a buffer 
whose composition was 20 mM MOPS pH 7.0, 100 mM KCl. The concentration of 
CaM used was 4 uM in the syringe. Concentration of the peptides to be used was 
calculated based on the affinity of binding measured from ITC experiments. The 
calculations are as follows: 
            From ITC data, we know the stoichiometry of binding of neurogranin and CaM is   
            1:1. So the binding equation is 
             Ng + CaM                 Ng-CaM 
                            
             [Ng-CaM] = Kon [Ng][CaM]- Koff [Ng-CaM] 
 
            Grouping similar terms, 
            (1+ Koff) [Ng-CaM] = Kon [Ng][CaM] 
 
            To determine the amount of neurogranin required for  90%  binding of neurogranin  
Kon 
Koff 
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       and CaM,  
       (1+ Koff) 0.9*CaM0 = Kon [Ng] (0.1* [CaM0]) 
        Since 1 << Koff , the equation becomes 
              9Kd = [Ng] (Kd = Koff / Kon) 
             [Ng]= [Ng]0-[Ng-CaM] 
             [Ng]0  = 9Kd + 0.9* CaM0 
           The stopped-flow equipment consists of two injection syringes which inject equal   
           volumes of liquid into a sample cell. The experiment is conducted by injecting equal  
           volumes of liquid from the two syringes which are mixed in the sample cell   
           following which fluorescence is measured. One of the syringes in our experiment  
           contains 150 µM Quin-2  and the other syringe contains CaM and neurogranin  
           peptides. The excitation wavelength was 334.5 nm and the detection of fluorescence  
           emission was controlled by a 435 nm cut-on filter (Oriel #51282). The slit widths  
           were set at 0.5 nm. 
b) Tyrosine fluorescence experiments: The tyrosine fluorescence experiments were  
also performed on the stopped-flow equipment. One syringe contained 10 µM CaM ,  
100 µM CaCl2 and neurogranin peptides at concentrations calculated as mentioned  
in the earlier section (to ensure 90% binding under any condition) in 20 mM MOPS 
pH 7.5, 100 mM KCl  and the other syringe contained 5mM EGTA in the same 
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buffer. The EGTA present in excess absorbs free calcium present. Hence calcium 
dissociating from CaM does not reassociate and fluorescence change can be 
measured accurately. Intrinsic tyrosine fluorescence was monitored at an excitation 
wavelength of 276 nm and emission was measured with a bandpass emission filter 
with peak transmittance at 355 nm (Oriel #51662).   
2.3 Protein expression and purification 
a) Neurogranin expression and purification: The cDNAs encoding the full-length 
RC3 protein was expressed from the pET23 vector in the BL21 DE3 pLys S strain of 
E. coli. The plasmids were cultured in LB medium with ampicillin and 
chloramphenicol. When the cultures reached an OD595 of 0.4-0.6, protein expression 
was induced with 200 mg/ml of IPTG and the cultures were maintained at 37°C for 6 
hours. The cells were harvested by centrifugation in a JA-10 rotor at a speed of 4000 
rpm for 20 minutes at 4°C. To purify RC3, the following steps were performed at 
4°C. Cell pellets were lysed in a cold hypotonic lysis buffer (1 mM HEPES, 1 mM 
DTT, 1 mM PMSF), with sonication. The lysate was centrifuged at 25,000 x g to 
remove particulate material. The supernatant was brought to 65% ammonium sulfate 
at 4°C, causing precipitation of RC3. After centrifugation at 10,000 x g for 30 min, 
the pellet was resuspended in 15 ml of 50 mM Tris, pH 6.8, 50 mM NaCl and 
perchloric acid was added to 2.5% final concentration. The mixture was centrifuged 
at 10,000 x g for 15 min, and then the supernatant was brought to 90% ammonium 
sulfate. After a final spin at 10,000 x g for 30 min, the pellet was resuspended in 10 
mM HEPES, 200 mM KCl and dialysed overnight into the same buffer. The next 
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day, protein concentration was calculated by measuring absorbance at 600 nm and 
the protein was used in experiments. 
b) CaM expression and purification: CaM was expressed in BL23 (DE3) star 
chemically competent cells using IPTG similar to the expression protocol of 
neurogranin. CaM was purified by resuspending the pellet in 25 ml lysis buffer (50 
mM Tris pH 7.5, 10 mM EDTA) following which the pellet was sonicated on ice. 
The lysate was spun at 39100 x g for 1 hour using a Beckman JA20 rotor. The 
supernatant was brought to 2.5 M ammonium sulfate at room temperature by 
addition of ammonium sulfate over a period of 30 minutes to an hour such that it gets 
into solution slowly. Following centrifugation at 12500 x g for 10 minutes in a JA 20 
rotor, the supernatant was brought to saturation with ammonium sulfate. The solution 
was centrifuged at 12500 x g for 10 minutes in a JA20 rotor and the pellet was 
resuspended in 50 ml of resuspension buffer (50 mM Tris, pH 7.5, 200 mM 
ammonium sulfate and 1 mM EDTA). The solution was then loaded over a phenyl 
sepharose column which was pre-equilibriated with resuspension buffer at room 
temperature. Calcium chloride was added to 2.5 mM final concentration from a 1M 
stock to Column I flow through. To the solution was added 200 mM ammonium 
sulfate slowly over a period of time and this mixture was then added to column II 
which was pre-equilibriated with wash buffer. To column II, elution buffer was 
added to elute the fractions and the fraction collected using a fraction collector. The 
absorbance of each fraction at 276 nm was measured and the fraction with the 
maximum OD was then dialysed overnight in 50 mM MOPS. The fraction was 
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concentrated the next day using a Centriplus 3000 MWCO (Millipore cat # 4420) at 
4°C. 
2.4 MATLAB simulations  
The purpose of these MATLAB simulations was to develop a model of interaction 
between neurogranin, CaM and calcium such that the model can be used to predict 
interactions under conditions that are difficult to measure experimentally. The model of 
interaction that I generated here is based on the law of mass action. Under the law of mass 
action, the rate at which a reaction progresses is dependent on the concentration of the 
reactants and the reaction rate constants. I wrote out ordinary differential equations (ODE) 
that described the rate of change of each species of CaM. Some of the kinetic constants used 
were values reported in literature from experiments. Other kinetic constants which cannot be 
experimentally determined were fixed by a method called parameter optimization which is 
described below. Once the constants were determined, the model was calibrated by ensuring 
that the principle of mass conservation was not violated under any condition. The ODE 
model was then used to run simulation experiments to predict different results which will be 
described below. 
a) ODE model generation: There are 9 different ‘species’ of CaM in the model based 
on the calcium saturated state of CaM. These are the apo-CaM, fully calcium-
saturated CaM and seven other species of CaM depending on the calcium- saturation 
state of the N-lobe or C-lobe of CaM. Similarly, there are 9 different ‘species’ of 
neurogranin bound CaM. There are a total of 66 rate constants that correspond to the 
rates of association and dissociation of neurogranin, CaM and calcium. Using 
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general principles that are proven through experiments, it is possible to arrive at 
certain relationships between the 66 kinetic constants such that the number of 
constants that need to be determined are 22. Of the 22 constants that need to be 
determined, 14 were determined using values in literature. There were 8 constants 
which were determined using the method of parameter optimization that began with 
a best guess value and arrived at the optimal value after a series of iterations. The 
parameter optimization process is described in the next section. 
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Figure 2.1: Pictorial representation of the ODE model with the different species and 
their reactions 
 
 
C0N0 represents apoCaM, C1N0-CaM with a partially saturated C-lobe, RC0N0- 
neurogranin bound apoCaM, RC2N2- neurogranin bound to fully saturated CaM. 
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b) Parameter Optimization: Parameter optimization refers to the method that was 
used to obtain the best possible parameters (on-rates and off-rates) in the ODE 
model. I used MATLAB simulations to search parameter space for the best possible 
parameters. The parameter space search was initiated using a seed set of parameters 
which were the best guess values for parameters. 
 Using the seed set of parameters, I wrote codes that replicated each of the 
experiments- ITC and stopped flow fluorimetry- in MATLAB. After each 
experiment was replicated, I plotted the data obtained in a form similar to what was 
obtained experimentally. I called this the result of my theoretically conducted 
experiments. I then plotted the experimental data from ITC and stopped-flow 
fluorimetry experiments. This was the experimental result. The theoretical result and 
experimental result were compared and the difference between them calculated. This 
was called the ‘error margin’. Based on the error margin, the seed set of parameters 
was updated. The whole process was repeated again with a new set of parameters 
that minimized the error values. The optimized parameters were obtained when the 
error margin was minimal and subsequent iterations with new parameter sets did not 
minimize the error margin. 
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c) Simulation experiments: Once the ODE model was calibrated and the parameters 
determined, I ran simulations to test different phenomena. When there is a calcium 
influx, the N-lobe of CaM saturates first followed by a redistribution of calcium to 
the C-lobe of CaM. To test the effect of neurogranin on CaM’s mode of calcium 
binding, I studied the time-dependent change in concentrations of N-lobe saturated 
CaM, C-lobe saturated CaM and fully saturated CaM following a calcium influx. 
One of the questions of great significance in studies on CaM is the effect that 
proteins binding to CaM have on CaM’s calcium binding properties. To address this 
question, I performed a simulation experiment where I introduced calcium (20 µM) 
into an equilibriated system of CaM (20 µM) and neurogranin (20 µM).  Following 
the injection of calcium into the system, I followed the concentrations of calcium-
saturated CaM, apo-CaM, apo-CaM bound to neurogranin and calcium-saturated 
CaM bound to neurogranin to study the effect of neurogranin on calcium saturation 
of CaM. The results of the experiment will be discussed and interpreted in the 
discussion section. In the next experiment, the steady-state concentrations of 
calcium-saturated CaM and neurogranin bound calcium-saturated CaM was 
determined at different concentrations of neurogranin. This is a direct test of the 
effect of neurogranin on calcium saturation of CaM. 
 
  
              
44 
 
 
CHAPTER 3 
RESULTS AND 
DISCUSSION 
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3.1 Overview 
CaM plays a pivotal role in synaptic plasticity since this protein is activated by 
binding to calcium following which it activates other molecules downstream, many of which 
affect plasticity at the synapse by a variety of biochemical and biophysical means. As the 
primary calcium signal transducer, CaM serves to transduce calcium signals that are intense, 
transient and diverse. CaM acts a versatile calcium sensor that responds to all these diverse 
calcium signals by virtue of having four calcium binding sites each of which have their own 
kinetic and equilibrium rates of calcium binding and dissociation. Furthermore, various 
proteins like small neuronal IQ domain proteins that interact with CaM alter the kinetics of 
calcium binding of some of these sites providing versatility to CaM.  
The protein of focus is neurogranin, a small neuronal IQ domain protein abundant in 
the neurons of hippocampus and frontal lobe cortex. Research into the interaction of 
neurogranin with CaM suggested that neurogranin accelerated the rate of calcium 
dissociation from CaM(Gaertner, Putkey, and Waxham 2004). To establish unequivocally 
the role of neurogranin in regulating CaM, it is necessary to have quantitative data on 
neurogranin’s interaction with CaM as well as its effect on the kinetics and dynamics of 
calcium binding to CaM. I used Isothermal Titration Calorimetry (ITC) to study the 
thermodynamics of CaM association with neurogranin and stopped-flow fluorimetry to 
study the kinetics of calcium binding to CaM in the presence of neurogranin peptides. In all 
my experiments, I used peptides that represent different regions of the protein and in some 
cases a phosphorylated state of the protein.  
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3.2 Thermodynamics of CaM association with neurogranin 
Thermodynamic analysis of the interaction of CaM with other molecules provides 
useful information on the regulation of CaM by a variety of these molecules. Studies on 
troponin I-CaM interaction as well as myosin light chain kinase-CaM interaction by Daniel 
Storm and colleagues demonstrated that the free energy coupling for each CaM-protein 
complex is unique and that protein interaction with CaM can change the free energy 
coupling for calcium binding to CaM(Olwin et al. 1984; Keller et al. 1982).To determine the 
energetics of calcium binding to CaM and the influence of neurogranin peptides, I used 
isothermal titration calorimetry (ITC) and measured the exothermic change that occurred 
when CaM interacted with neurogranin peptides or the protein. Some of the experiments 
were conducted in a buffer containing 50 mM HEPES in the presence of 150 mM KCl to 
mimic physiological ionic concentrations. 
In this section, I will focus on the dissociation constant values obtained from the ITC 
measurements and aim to interpret them in the context of the underlying biology. 
Dissociation constant, Kd is a specific type of equilibrium constant that is used as a measure 
of the propensity of a complex to dissociate into its component molecules. Kd is also defined 
as the ratio of the off-rate constant and on-rate constant: 
Kd = koff/kon  
where koff is the off-rate constant that is the rate of the reverse reaction and kon is the on-rate 
constant that refers to the rate of the forward reaction. When a reaction between molecules 
has a high Kd, it means that either the off-rate constant has a high value or the on-rate 
constant has a low value or it is a combination of both. Hence, there is an inverse 
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relationship between Kd and affinity and an increase in Kd indicates reduced affinity and 
vice versa.  
3.2.1 RC3 (26-49) interaction with CaM 
I began thermodynamics study on the neurogranin peptides with RC3 (26-49) 
peptide. The RC3 (26-49) peptide contains only the IQ domain region of the peptide with a 
few amino acids N-terminal to it. NMR and CD spectroscopy studies on the neurogranin 
protein have established that this region of the protein forms an α-helix upon binding to apo-
CaM in the presence of salt (Gerendasy et al. 1995; Ran et al. 2003) Furthermore, chemical 
shifts of the residues in the neurogranin protein show that many residues in the IQ region of 
the protein show significant structural changes upon binding to CaM(Ran et al. 2003). NMR 
data along with stopped-flow fluorimetry data on PEP-19 peptides also indicated that the IQ 
domain region of the peptide provides a targeting function that allows binding to 
CaM(Putkey et al. 2008). Since a key role has been attributed to the IQ domain of 
neurogranin in binding to CaM, I wanted to determine the binding affinity of the IQ domain 
region of neurogranin to CaM.  
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          Figure 3.1: Result of RC3 (26-49) peptide interaction with CaM 
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Discussion of RC3 (26-49) result: 
The RC3 (26-49) peptide bound with high affinities of 0.63 µM to apo-CaM and 
0.87 µM to calcium-CaM in the absence of salt. Interestingly, binding in the presence of salt 
was below detection. Crystal structure studies by Quiocho and colleagues on skMLCK and 
CaMKII binding to CaM showed that CaM formed a compact structure with a hydrophobic 
tunnel that runs at an angle of 45 degrees to the long axis of the protein(Meador, Means, and 
Quiocho 1992; Meador, Means, and Quiocho 1993). The target peptide in both the above 
cases formed an α-helix whose hydrophobic residues interacted with the hydrophobic tunnel. 
The length of the α-helix dictated the degree of compactness of CaM. It is possible that RC3 
(26-49), a short peptide, which forms an α-helix upon interacting with CaM, does not cause 
CaM to form a highly compact structure and hence there are fewer points of contact between 
the peptide and the protein. The crystal structure of RC3(27-50) peptide interaction with 
CaM predicts that there are three residues- Ile 33,Ser 36 and Arg 38 that mainly interact with 
Cam residues. Presence of salt might be able to easily disrupt the interactions.   
3.2.2 RC3 (13-49) interaction with CaM 
The acidic domain N-terminal to the IQ domain has been implicated in binding as 
well. Hence I next studied the RC3 (13-49) peptide which has both the IQ domain region 
and the acidic region N-terminal to it. Represented below in figures are the ITC data for 
binding between RC3 (13-49) peptide and CaM under different conditions 
(absence/presence of saturating concentrations of calcium, 150 mM KCl).  
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Figure 3.2: Result of RC3 (13-49) peptide interaction with CaM- No salt present 
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Figure 3.3: Result of RC3 (13-49) peptide interaction with CaM- Salt present 
 
 
 
 
 
52 
 
Discussion of RC3 (13-49) results: 
In the absence of salt, RC3 (13-49) peptide bound with a high affinity Kd of 0.066 
µM to apo-CaM. Binding to calcium/CaM was much weaker with a Kd of 1.25 µM that is 18 
times lower. In the presence of physiological concentrations of salt (150 mM KCl), the 
affinity of binding to apo-CaM weakened ten-fold with a Kd of 0.64 µM. The affinity of 
calcium/CaM to neurogranin was 2.4 fold lower in the presence of salt with a Kd of 3.01 
µM. (The number of trials for each peptide for each condition was 2). 
Earlier work on the PEP-19 peptides and the protein indicated that the IQ domain 
provided a targeting function that allowed binding of PEP-19 to CaM whereas the acidic 
domain modified the nature of this interaction and was essential for modulating calcium 
binding to the C-domain of CaM(Putkey et al. 2008). Thus both the IQ domain and the 
acidic domain N-terminal to it were deemed necessary for binding of PEP-19 and CaM.  The 
RC3 (13-49) results suggest that the regions of the neurogranin protein behave in a similar 
fashion to the PEP-19 protein. 
3.2.3 RC3 Protein 
                 In order to determine with certainty that the RC3 (13-49) peptide behaved in a 
very similar fashion to the RC3 protein and also to study the properties of the protein itself, I 
measured the enthalpy, entropy and binding affinity of the RC3 protein.                                                                                      
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           Figure 3.4: Result of RC3 protein interaction with CaM 
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Discussion of RC3 protein results 
The neurogranin protein bound to apo-CaM with an affinity of 0.071 µM similar to 
that of the RC3 (13-49) peptide (Kd of 0.066 µM). Kd for interaction between calcium-CaM 
and neurogranin protein was 1.39 µM similar again to RC3 (13-49) peptide which had a Kd 
of 1.25 µM. These interactions were in the absence of salt. However, in the presence of salt, 
binding between the neurogranin protein and CaM was below detection.  
3.2.4 RC3 (13-52) peptide interaction with CaM 
NMR characterization of the neurogranin-CaM interaction led to the identification of 
residues in neurogranin that showed significant chemical shifts and hence are hypothesized 
as regions of interaction between CaM and neurogranin(Ran et al. 2003). Three acidic 
residues E, C and G which are C-terminal to the IQ motif were found to show significant 
chemical shifts and hence it is believed that these three residues are important for 
neurogranin-CaM interaction. To test the contribution of these residues in binding, we 
created a peptide with the three residues added to the C-terminal of the RC3 (13-49) peptide. 
I measured the binding affinity between this peptide and CaM using ITC measurements.  
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     Figure 3.5: Result of RC3 (13-52) peptide interaction with CaM-No salt 
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Figure 3.6: Result of RC3 (13-52) peptide interaction with CaM- salt present 
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Discussion of RC3 (13-52) peptide results 
In a demonstration that greater number of points of contact need not correspond to 
increased affinity, the Kd between the RC3 (13-52) peptide and apo-CaM was found to be 
0.158 µM which is 2.5 times higher than the Kd between RC3 (13-49) peptide and apo-CaM 
in the absence salt. Similarly, Kd of binding of RC3 (13-52) to calcium-CaM was 2.36 µM 
compared to 1.25 µM for RC3 (13-49) peptide. The dissociation constants were 0.91 µM 
and 4.61 µM for interaction between RC3 (13-52) peptide and apo-CaM and calcium-CaM 
respectively in the presence of 150 mM KCl. These values are only modest increases of 1.4 
fold from the 0.64 µM measured with RC3 (13-49) for apo-CaM interaction and 1.5 fold 
from the value of 3.01 µM for calcium-CaM interaction with RC3 (13-49). 
3.2.5 RC3 (S36D) peptide with CaM 
Phosphorylation of neurogranin by protein kinase C is a feedback mechanism that 
regulates activity of neurogranin by potentially changing its affinity to CaM. Observations 
made by Ramakers and group on the phosphorylated state of neurogranin following 
induction of long-term potentiation and long-term depression strengthened the idea of 
phosphorylation as a feedback mechanism for neurogranin regulation (Ramakers et al. 
1995).  
The S36D variant of neurogranin has been used as a phospho-mimetic in literature 
(Gerendasy et al. 1994)where competition experiments showed that this variant bound with 
lower affinity to CaM than the wildtype protein. I determined the binding affinity of this 
variant with CaM in the presence and absence of salt.  
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       Figure 3.7: Result of RC3 S36D peptide interaction with CaM- No salt  
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Discussion of RC3 (S36D) peptide results 
In the absence of salt, RC3 S36D peptide bound to apo-CaM with a Kd of 2.29 uM 
and to calcium-CaM with a Kd of 5.27 uM. In the presence of salt, binding was below 
detection.  Calcium binding experiments with calbindin D9k demonstrated that salt serves to 
shield the charges on the surface of calbindin D9k(Linse, Helmersson, and Forsén 1991; 
Linse et al. 1988). It is possible that the presence of salt shields the negative charge of RC3 
S36D and reduces binding affinity to below detectable levels.  
3.2.6 RC3 (13-49) peptide with CaM at high temperature 
I next looked at the behavior of the RC3 (13-49) peptide at higher temperatures 
(37°C) to study the effect of temperature on binding affinities.  
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  Figure 3.8: Result of RC3 (13-49) peptide interaction with CaM at 37°C- No salt 
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  Figure 3.9: Result of RC3 (13-49) peptide interaction with CaM at 37°C- Salt present 
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Discussion of RC3 (13-49) at high temperature 
The dissociation constant between apo-CaM and RC3 (13-49) peptide at 37°C in the 
absence of salt was 0.43 µM whereas at 25°C it was 0.066 µM. Dissociation constant 
between apo-CaM and RC3(13-49) peptide in the presence of 150 mM KCl at 37°C was 
2.64 µM  and at 25°C  it was 0.639 µM. In contrast, dissociation constant between RC3(13-
49) peptide and calcium-CaM was not very different being 1.86 µM in the absence of salt at 
37°C and 1.25 µM at 25°C. The dissociation constant between calcium-CaM and RC3 (13-
49) in the presence of salt at 25°C was 3.01 µM and at 37°C it was 4.59 µM. 
A common theme running through all the binding data from ITC experiments is that 
salt lowers the binding affinity between neurogranin peptides and CaM. There is precedent 
for this effect in literature. The effect of salt on affinity of binding between CaM and P-57 
(neuromodulin) was examined by Daniel Storm and colleagues (Alexander et al. 1987). 
They determined that the dissociation constant (Kd) between apo-CaM and P-57 increased 
from 0.23 µM in the absence of salt to 3.4 µM in the presence of 150 mM KCl. The 
dissociation constant (Kd) between calcium-CaM and P-57 increased from 1 µM in the 
absence of salt to 3 µM in the presence of 150 mM KCl. 
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Table 3.1: Summary of affinity of interaction between CaM and neurogranin 
protein/peptides 
 
 
 
3.3 Enthalpic and entropic changes associated with CaM-neurogranin interaction 
Enthalpy is a measure of the total energy needed by a thermodynamic system. It is 
used as a measure of the changes in physical, chemical and biological measurements in a 
system. Entropy is yet another mathematically defined function that helps to account for the 
heat flow through a thermodynamic system. The statistical mechanics interpretation of 
entropy is that it is a measure of randomness or disorder in a system. However, it is also 
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possible to use entropy to study protein-protein interaction. When proteins interact, 
hydrophobic surfaces are buried and hydrophilic surfaces are exposed to the solvent. There 
is release of water when hydrophobic surfaces get buried within the protein also known as 
‘energy of hydration’. There is an entropic change associated with this energy of hydration 
called solvent entropy. There are changes to rotational freedom of individual residues within 
each protein as proteins interact and these changes are encapsulated as conformational 
entropy. There is also another entropy term called vibrational entropy which is the change in 
vibrational flexibility of protein when secondary structures are stabilized(Schuler, Lipman, 
and Eaton 2002; Cho et al. 1996).  
Linse and colleagues devised an effective way to use thermodynamic measurements 
to study the effect of individual charged residues on calcium binding to the protein calbindin 
D9K(Linse et al. 1988). This group measured macroscopic binding constants by titrating 
different mutants of calbindin D9K (mutations were made to neutralize the different charged 
residues) with calcium in the presence of calcium chromophores BAPTA or Quin-2 and 
measuring the change in absorbance at 263 nm. From the macroscopic binding constants, 
free energy change was calculated and the effect of each charged residue on free energy 
change and its biological implication was predicted.   
I explained the concepts of entropy and enthalpy as well as ways in which 
measurements on biological systems are used to determine thermodynamic constants that are 
then used to interpret the underlying biology because I will be performing similar 
calculations to calculate free energy and attempt to interpret the data in a similar fashion. 
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In my calorimetry experiments, I used a single mutant peptide RC3 S36D and other 
peptides to determine change in entropy and enthalpy. Using these thermodynamic 
measurements, I calculated ∆G, Gibbs free energy as follows. At constant temperature, 
                                                ∆G = ∆H - T∆S  
Table 3.2: Enthalpic and entropic changes following RC3 peptide interaction with 
CaM
 
Looking across the table of enthalpy, entropy values there are no immediate 
conclusions that can be drawn based solely on the values as there seems to be no pattern that 
emerges within the values. However, calculation of free energy for each interaction provides 
insight into the nature of interaction between RC3 peptides and CaM and calcium.  
For instance, the free energy of interaction of calcium to RC3 (26-49) peptide and 
CaM can be calculated by subtracting the free energy value obtained for RC3 (26-49) 
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interaction with apo-CaM from the value obtained for RC3 (26-49) interaction with calcium-
CaM. Similar calculations can be made for each of the other peptide- CaM interactions. The 
results show that the free energy for calcium interaction with RC3 (26-49) peptide-CaM 
complex is -10763.15 kcal in comparison to 1785.2 kcal for calcium interaction with RC3 
(13-49) peptide-CaM complex. The biological significance of this finding is that the affinity 
of calcium is decreased 6-fold when RC3 (13-49) peptide is in complex with CaM.  
RC3 S36D has a free energy change of 541.75 kcal for interaction with calcium. 
Comparing it to the value obtained for RC3 (13-49) peptide- 1785.2 kcal, it shows that 
mutation of a single residue in RC3 (13-49) resulted in a 3.3 fold reduction in calcium 
affinity. Finally, based on free energies of calcium binding, the RC3 (13-49) peptide is the 
peptide that best mimics RC3 protein.  
3.4 Kinetics of calcium binding 
The rate of calcium binding is a constant of interest since biological systems are 
dynamic systems where changes could occur within a few milliseconds. To study the 
kinetics of calcium binding to CaM, I used two different readouts. In one set of experiments, 
I studied fluorescence changes in the tyrosine residues intrinsically present in the C-terminal 
lobe of CaM. CaM has two tyrosine residues in the C-terminal lobe. Tyrosine is excited at 
276 nm and peak emission at 304 nm is monitored. When calcium binds to the C-terminal 
lobe of CaM there is a change in tyrosine fluorescence. This change in fluorescence is 
plotted against the free calcium concentration to obtain the Kd of calcium binding. The other 
readout I used is the fluorescence of a calcium chromophore, Quin-2. The excitation 
wavelength is 334.5 nm and the emission at 435 nm is measured. Quin-2 fluorescence 
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increases upon binding calcium. The advantage in using the Quin-2 system is that it can 
measure all calcium released from CaM as opposed to tyrosine fluorescence which measures 
only the calcium released from the C-terminal of CaM. 
In the first set of experiments, I measured increase in Quin-2 fluorescence as calcium 
dissociated from CaM. Quin-2 is a calcium chelator with a high affinity towards calcium (Kd 
of 74 nM) and an extremely fast on-rate of calcium binding-10
9
 M
-1
 S
-1
(Lakowicz et al. 
1992; Bayley et al. 1984)which makes it a suitable calcium chelator to measure calcium 
dissociation from CaM.  
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3.4.1 Quin-2 fluorescence of calcium dissociation from CaM 
 Figure 3.10: Fluorescence due to calcium release from CaM measured using Quin-2, a 
calcium dye        
 
Discussion of calcium dissociation from CaM measured from Quin-2 fluorescence 
Calcium dissociation rate (koff) from CaM was at the rate of 12.93 s
-1
 at 22°C. 
Stopped flow experiments by Putkey and group under similar experimental conditions 
yielded a dissociation rate of 9.9±0.4 s
-1 
for calcium dissociation from CaM(Putkey et al. 
2008). A value of 9.1±0.6 s
-1
 was reported for calcium dissociation from CaM under 
identical conditions in (Gaertner, Putkey, and Waxham 2004).Values for calcium 
dissociation from the C-domain of CaM using stopped flow were reported between 8.5 s
-1 
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and 12.6 s
-1
(Peersen, Madsen, and Falke 1997; Persechini, White, and Gansz 1996). The 
value of 12.93 s
-1
that I report here aligns well with the values reported in literature. 
 
3.4.2 Quin-2 fluorescence for RC3 (13-49) peptide complex with CaM 
 Following the measurement with CaM, I studied the effect of the RC3 (13-49) 
peptide on the calcium dissociation rate from CaM. Kinetic studies on peptides of PEP-19, 
another SNIQ domain protein family member indicated that the peptide containing the IQ 
domain along with a few residues N-terminal to the IQ domain accelerated calcium release 
from CaM to 390±40 s
-1 
from 9.9±0.4 s
-1 
(Putkey et al. 2008). Since the IQ domain of PEP-
19 and neurogranin share sequence homology, it was an interesting question to see if the 
neurogranin long peptide behaved in an analogous manner to PEP-19 (28-62).  
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Figure 3.11: Fluorescence due to calcium release from CaM in the presence of        RC3 
(13-49) peptide measured using Quin-2, a calcium dye          
 
 
Discussion of quin-2 fluorescence with RC3 (13-49) peptide interaction with CaM 
The neurogranin long peptide accelerated calcium dissociation to 447.25 s
-1
, a 35-
fold increase in koff rate from that of CaM (12.93 s
-1
) just like the 39-fold increase in koff  rate 
from 9.9±0.4 s
-1 
to 390±40 s
-1 
caused by PEP-19 (28-62). This suggests that the domains of 
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neurogranin interact with CaM to cause functional changes in a manner similar to the 
domains of PEP-19. 
 
3.4.3 Quin-2 fluorescence of RC3 (26-49) peptide interaction with CaM 
I next studied the effect of the IQ domain of neurogranin on calcium dissociation 
from CaM. Earlier work on the IQ domain of PEP-19 indicated that the IQ domain of PEP-
19 reduced the dissociation rate by a factor of 3 from 9.9±0.4 s
-1 
to 3.2±0.3 s
-1
(Putkey et al. 
2008).   
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Figure 3.12: Fluorescence due to calcium release from CaM in the presence of RC3 
(26-49) peptide measured using Quin-2, a calcium dye                 
 
 
 
Discussion of quin-2 fluorescence RC3 (26-49) peptide in complex with CaM 
The IQ domain of neurogranin also reduced the dissociation rate of calcium from 
CaM from 12.93 s
-1
 to 2.032 s
-1
 (6 times lower) similar to the IQ domain of PEP-19 which 
reduces the rates of calcium dissociation. 
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3.4.4 Quin-2 fluorescence of RC3 (13-52) peptide interaction with CaM  
Structural and dynamic characterization of neurogranin interaction with CaM using 
NMR revealed the involvement of residues glutamate, cysteine and glycine at the C-terminal 
end of neurogranin in binding CaM (Ran et al. 2003). I looked at the effect of the peptide 
containing residues D13 to G52 on calcium dissociation from CaM.  
Figure 3.13: Fluorescence due to calcium release from CaM in the presence of RC3 
(13-52) peptide measured using Quin-2, a calcium dye                  
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Discussion of Quin-2 fluorescence of RC3 (13-52) peptide interaction with CaM  
The RC3 (13-52) peptide unlike the RC3 (13-49) peptide caused two rates of calcium 
dissociation. One of the rates is the same as calcium dissociation from the C-terminal lobe of 
CaM. At first pass it would seem that the RC3(13-52) peptide does not change calcium 
dissociation rate from the C-terminal lobe but on comparison with tyrosine fluorescence it 
would appear that the RC3 (13-52) peptide affects the kinetics of calcium dissociation in a 
complex way. 
3.4.5 Tyrosine fluorescence of CaM 
I looked at intrinsic tyrosine fluorescence from the C-terminal lobe of CaM. CaM 
has two tyrosine residues in its C-terminal lobe which can be excited at 280 nm. The 
fluorescence at 304 nm is measured which determines the calcium bound state of the C-
terminal lobe of CaM. Tyrosine fluorescence determined in tandem with Quin-2 
fluorescence helps delineate the effect of neurogranin peptides on calcium dissociation from 
the C-terminal lobe and N-terminal lobe.  
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Figure 3.14: Fluorescence due to calcium release from CaM measured using intrinsic 
tyrosine fluorescence 
 
 
Discussion of tyrosine fluorescence of CaM 
Tyrosine fluorescence measurements of CaM resulted in a rate of 11.67 s
-1
.This falls 
well within the range of values reported in literature for calcium dissociation from the C-
terminal lobe of CaM ((Peersen, Madsen, and Falke 1997; Persechini, White, and Gansz 
1996)).  
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3.4.6 Tyrosine fluorescence of RC3 (13-49) peptide with CaM 
I next looked at tyrosine fluorescence of CaM in the presence of RC3 (13-49) peptide. By 
comparing the quin-2 fluorescence and tyrosine fluorescence results it is possible to 
delineate the effect of each of the peptides on calcium binding and dissociation from C-
terminal lobe and the N-terminal lobe of CaM. 
Figure 3.15: Fluorescence due to calcium release from CaM in the presence of RC3 
(13-49) peptide measured using intrinsic tyrosine fluorescence          
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Discussion of RC3 (13-49) peptide interaction with CaM 
The tyrosine fluorescence results show that the RC3 (13-49) peptide accelerates calcium 
dissociation from the C-terminal of CaM to 285.79 s
-1
. Comparing this result with the quin-2 
fluorescence, it is clear that the calcium that dissociated from CaM and was reported by 
quin-2 was not from the C-lobe alone. The calcium coming off from the N-lobe was also 
partially reported by quin-2 fluorescence. 
3.4.7 Tyrosine fluorescence of RC3 (26-49) peptide with CaM 
Figure 3.16: Fluorescence due to calcium release from CaM in the presence of RC3 
(26-49) peptide measured using intrinsic tyrosine fluorescence                     
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Discussion of RC3 (26-49) peptide interaction with CaM 
The RC3 (26-49) peptide decelerated the rate of calcium dissociation to 2.83 s
-1
. 
Comparing this result with the quin-2 fluorescence result (2.032 s
-1
), this peptide does not 
seem to affect the N-lobe calcium dissociation rate. 
3.4.8 Tyrosine fluorescence of RC3 (13-52) peptide with CaM 
Figure 3.17: Fluorescence due to calcium release from CaM in the presence of RC3 
(13-52) peptide measured using intrinsic tyrosine fluorescence                      
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Discussion of RC3 (13-52) peptide  interaction with CaM 
In an interesting result, tyrosine fluorescence of the RC3 (13-52) peptide indicates 
that this peptide accelerated calcium dissociation from the C-terminal lobe and hence one of 
the rates of 10.66 s
-1 
observed with quin-2 fluorescence cannot simply be assigned to C-
terminal lobe. The result with this peptide seems anomalous in trying to determine its effect 
on calcium dissociation from CaM.  As this thesis was being written, experiments conducted 
by others in our lab with this peptide suggested that the peptide was contaminated. The 
purified peptide showed different results. Hence, it appears that one of the two rates 
obtained using quin-2 fluorescence was an artifact. 
Table 3.3: Summary of kinetics of calcium dissociation from CaM in the presence of    
neurogranin peptides 
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3.4.9 Summary and discussion 
The results show that the IQ domain region of neurogranin alone is not sufficient to 
mimic the entire protein. Additional residues at the C-terminal and N-terminal end of the IQ 
domain significantly impact the behavior of the peptides. Another result from the series of 
experiments is that an aspartate at the serine 36 position does not mimic phosphorylation of 
the residue. These are important results to bear in mind while using neurogranin peptides to 
study the behavior of this protein.  
Another result with biological implications is the behavior of different SNIQ domain 
proteins in regulation of CaM. From the peptide studies, it is clear that the different regions 
of PEP-19 and neurogranin are functionally similar in terms of their ability to accelerate or 
decelerate calcium off-rates. However, PEP-19 in addition to accelerating calcium off-rates 
also accelerates calcium on-rates (X. Wang et al. 2010) whereas neurogranin accelerates 
only calcium off-rates (Gaertner, Putkey, and Waxham 2004). In the brain, PEP-19 is 
primarily expressed in the cerebellar purkinje cells whereas neurogranin is expressed in the 
CA1 and CA3 regions of the hippocampus and regions of the frontal cortex. Both these 
proteins regulate CaM’s ability to transduce calcium signals by acting as a calcium buffer. 
Experiments in the hippocampal regions of rat brain suggest that regulation of postsynaptic 
calcium through modulation of extrusion and/or buffering regulates expression of long-term 
potentiation in the CA2 and potentially other brain regions(Simons et al. 2009). Since the 
cerebellum and hippocampus have different calcium dynamics, it is likely that neurogranin 
and PEP-19 evolved to specifically handle calcium signaling in that region of the brain. 
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CHAPTER 4 
GENERAL DISCUSSION 
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4.1 Overview  
In the final section of my thesis, I will describe the role of neurogranin as a regulator 
of the calcium transducing protein, CaM based on my quantitative study of the binding 
affinity of neurogranin peptides with CaM and the effects of these peptides on the kinetics of 
calcium binding to CaM. This quantitative study has helped delineate the role of 
neurogranin on the time-dependent distribution of CaM and calcium bound CaM following 
calcium influx into neurons and the equilibrium concentrations of these species.  
The emerging story on neurogranin is that like other members of the small neuronal 
IQ domain protein (SNIQ) family, this protein serves to alter the kinetics of calcium binding 
to CaM which in turn fine tunes calcium signaling following calcium influx into the neuron. 
As is evident from the data reported in literature, the kinetics of calcium influx and signaling 
following this event are in the order of a few milliseconds and involve a few micromolar of 
calcium influx ((Spruston et al. 1995; Sabatini, Oertner, and Svoboda 2002; Maravall et al. 
2000)). In order to transduce a calcium signal of such short duration and strength, the spatial 
and temporal distribution of CaM is critical. 
I used peptides of neurogranin that represent different regions of the neurogranin 
protein in my experiments. In the first section, I will address the issue of the peptide that 
best mimics the protein by comparing the thermodynamic binding affinity results from the 
peptides and the protein. I will next address the effect that each of the neurogranin peptides 
have on calcium binding to CaM by calculating the free energy of calcium binding to CaM 
in the presence of each of the peptides and calculating the dissociation constant from the free 
energy value. Finally, a computational model of CaM interaction with neurogranin and 
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calcium was built using MATLAB. Using the binding affinity information obtained from 
calorimetry experiments and the calcium binding kinetics data obtained from the fluorimetry 
data, I have constrained the parameters of the model. In the last section of discussion, I 
address the effect of neurogranin on the concentration of calcium-saturated CaM which is 
the CaM species that activates downstream targets.  
4.2 Characterization of domains of neurogranin required for its function 
To characterize the functional domains of neurogranin, peptides encompassing 
different regions were synthesized. In selecting regions of neurogranin critical for its 
function, the IQ domain region is the focus due to sequence homology between the IQ 
regions of neurogranin (RC3), GAP 43 and PEP 19(see figure below). I used three different 
peptides each of which contained the IQ region of the protein along with residues at either 
the N-terminal or the C-terminal which have been suggested to play an important functional 
role.  
The three peptides are: RC3 (26-49) which is the shortest peptide containing the IQ 
region and a few residues N-terminal to it, RC3 (13-49) which encompasses the IQ region 
and acidic residues N-terminal to it which are believed to play a critical role in functional 
interaction with CaM and RC3 (13-52) the longest peptide synthesized. I also purified the 
neurogranin (RC3) protein and used it in my experiments. 
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  Figure 4.1:  Different domains of neurogranin protein 
 
 
To determine the peptide that best mimics the protein, I determined binding affinities 
using isothermal titration calorimetry. The experiment was performed as described in the 
materials and methods section. The results indicate that the RC3 (13-49) peptide interacted 
with    apo-CaM with an affinity of 0.066 µM and bound to calcium-CaM with an affinity of 
1.25 µM. Thus, functionally the RC3 (13-49) peptide mimics the protein itself which bound 
to apo-CaM with an affinity of 0.071 µM and to calcium-CaM with an affinity of 1.39 µM. 
These results align with the properties of PEP-19 peptides where the peptide containing the 
IQ domain and an acidic domain N-terminal to it functionally mimics the full protein(Putkey 
et al. 2008). 
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Table 4.1 Binding affinities of neurogranin (RC3) peptides and protein 
 
To mimic PKC phosphorylation, we used two peptides with modifications to the 
serine residue in the IQ domain of RC3. The RC3 S36D peptide has a serine residue that is 
replaced by aspartate that imparts a negative charge at that position similar to a 
phosphorylated residue. The RC3 S36P residue has a phosphorylated serine at the 36
th
 
position instead of serine.        
The ITC results indicate that while the affinity of RC3 S36D peptide for apo-CaM is 
2.29 µM (number of trials=2) and affinity towards calcium-CaM is 5.27 µM (number of 
trials=2), the affinity of RC3 S36P peptide for CaM is below detection.   
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Table 4.2: Binding affinities for peptides with phospho modifications at serine residue 
                         
The ITC results with RC3 S36P and RC3 S36D indicate that the RC3 S36D peptide 
does not mimic phosphorylation of serine at the 36
th
 position. In literature, the RC3 S36D 
peptide has been used as a phospho-mimetic (Gerendasy et al 1994). This is an important 
conclusion from our work on the characterization of domains of neurogranin required for its 
function. 
 
4.3 Free energy of calcium binding to CaM in the presence of neurogranin peptides 
and protein 
Free energy of calcium binding to CaM in the presence of the various neurogranin 
peptides can be calculated using a scheme similar to the one used by Storm and colleagues 
for calculation of calcium binding to CaM in the presence of troponin I (TnI) (Keller et 
al.,1982).  
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Figure 4.2: Scheme for calculation of free energies of calcium and neurogranin peptide 
binding to CaM 
 
Applying the principle of conservation of free energy to the scheme above, 
4∆G°(C/R) = ∆G°(R/C4) - ∆G°(R) +4 ∆G°(C)  
 
Free energies can be calculated using the formula 
 ∆G°= RTln(Kd) 
∆G°(R/C4) is the free energy of neurogranin binding to calcium/CaM, ∆G°(R) is the free 
energy of neurogranin binding to apo-CaM, ∆G°(C) is the free energy of calcium binding to 
CaM. ∆G°(C) is calculated from the dissociation constant values reported in literature. 
∆G°(R/C4) and ∆G°(R) values are calculated from the dissociation constants measured for 
each of these peptides from ITC measurements.  
The calculated values are reported in the table below and the last column represents 
the dissociation constant for calcium binding to CaM in the presence of each of these 
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peptides/protein. From the table below, the conclusion is that when RC3 (26-49) peptide is 
present, the calcium affinity of CaM is twice as high when compared to the calcium affinity 
of CaM in the presence of neurogranin protein or any of the peptides that contain the acidic 
domain in addition to the IQ domain of neurogranin. Furthermore, the full protein and the 
RC3 (13-49) peptide are identical in their ability to alter calcium affinity toward CaM based 
on the dissociation constant values. The RC3 (13-52) peptide bound to CaM also shows a 
very similar dissociation constant to both the full protein and RC3 (13-49) peptide indicating 
that the acidic residues N-terminal to the IQ domain along with the IQ domain are important 
for the function of the protein. 
Table 4.3 
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4.4 Simulations of the effects of neurogranin on calcium saturation of CaM and 
putative mechanism of neurogranin interaction with CaM 
To study the effect of neurogranin on the concentrations of different species of CaM                  
(apo-CaM, partially saturated CaM, saturated CaM), I ran simulations in MATLAB. In the 
first simulation I wanted to study the effect of neurogranin on calcium binding to CaM. One 
of the salient features of calcium binding to CaM is that upon calcium influx, the N-lobe of 
CaM initially saturates with calcium following which calcium redistributes to the C-lobe of 
CaM. This occurs within the first few milliseconds and the effect is best studied using 
simulations. I simulated calcium binding to CaM in the absence of neurogranin by running 
the simulation with a CaM concentration of 21 µM, a sub-saturating calcium concentration 
of 56 µM and followed the concentrations of N-lobe saturated CaM, C-lobe saturated CaM 
and fully saturated CaM. The figure below is the simulation result. 
 What I saw was that the N-lobe of CaM (shown in green) was quickly saturated with 
calcium and showed an increase in concentration. This was followed by a redistribution of 
calcium to the C-lobe of CaM which resulted in a slower rise in the concentration of C-lobe 
saturated CaM and fully saturated CaM. 
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Figure 4.3: Distribution of calcium among the lobes of CaM in the absence of 
neurogranin 
 
 
I then added 21 µM neurogranin to the simulation and noticed that calcium binding 
to CaM followed the same pattern indicating that neurogranin does not change the mode of 
calcium binding to CaM.  However, neurogranin reduces the equilibrium concentration of 
calcium saturated CaM as well as the concentration of the other species of CaM. 
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Figure 4.4: Distribution of calcium among the lobes of CaM in the presence of 
neurogranin 
                       
 
After establishing that neurogranin does not change the mode of calcium binding but 
reduces the equilibrium concentration of CaM species, I chose to look at four different 
species namely, CaM, neurogranin-bound CaM, fully calcium saturated CaM, fully saturated 
neurogranin bound CaM. 
The simulation results show that neurogranin quickly complexes with CaM and upon 
calcium influx the concentration of CaM in complex with neurogranin binds to a larger 
proportion of calcium than un-complexed CaM. This is an interesting and unexpected result 
because neurogranin accelerates calcium release from CaM. Hence, the prediction was that 
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there would be a transient increase in saturation of neurogranin complexed with CaM 
followed by a drop in the concentration. At first pass, this result suggests that the 
concentration of neurogranin-bound CaM is extremely high and serves to drive the reaction 
in a direction that is kinetically unfavorable. In an attempt to better understand this result as 
well as dissect the mechanism by which the calcium saturated states of CaM and 
neurogranin bound CaM are populated, I looked at the concentrations of the partially 
saturated CaM and neurogranin-bound CaM species. 
Figure 4.5: Concentrations of CaM and Neurogranin bound CaM species 
 
A look at the partially saturated species of CaM and neurogranin CaM showed that 
neurogranin bound CaM species was short-lived. In combination with the earlier result, this 
suggests that neurogranin bound CaM is quickly saturated with calcium which is extremely 
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unfavorable kinetically. When considering that the rate of decay of the partially saturated 
species to its apo-form is 30 fold higher than the rate of generation of calcium –saturated 
CaM species, the conclusion is that for such a kinetically unfavorable reaction to proceed, 
the driving force must be exceptionally high. The driving force is the concentration of 
neurogranin. 
Figure 4.6: Concentrations of partially saturated CaM and Neurogranin bound CaM 
species 
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                                                Figure 4.7 
 
Finally, I studied the effect of neurogranin on the equilibrium concentrations of CaM and 
neurogranin-bound CaM. I repeated this simulation with two different concentrations of 
calcium influx.  
 
 
 
 
 
 
 
95 
 
Figure 4.8: Equilibrium concentrations of CaM and Neurogranin/CaM species with   
56 µM calcium influx 
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Figure 4.9: Equilibrium concentrations of CaM and Neurogranin/CaM species with   
133 µM calcium influx 
              
 
The results show that above a certain concentration of neurogranin (a sub-equimolar 
concentration), neurogranin bound CaM is primarily calcium saturated. Below that 
concentration, the concentration of saturated CaM dominates. This result has implications 
for the biological role of neurogranin as post-translational modifications like 
phosphorylation reduce the concentration of neurogranin available to bind to CaM which 
could influence the population of the calcium saturated state of CaM.   
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4.5 Conclusions and Future Experiments 
In this thesis, I studied the effect of neurogranin on calmodulin’s ability to interact 
with calcium. I used biophysical techniques like isothermal titration calorimetry to measure 
the binding affinity between peptides representing different domains of neurogranin and 
calmodulin and stopped-flow fluorimetry to measure calcium dissociation from calmodulin 
in the presence of neurogranin peptides. I also performed simulations in MATLAB to 
predict the effect of the peptides on calcium saturation of CaM.  
From my results, the overall conclusions are 
• The minimal IQ domain of neurogranin (RC3(26-49)) does not mimic the full 
protein 
• The IQ domain along with acidic residues N-terminal to it (RC3(13-49)) mimics the 
protein best 
• Replacement of serine residue within the IQ domain of neurogranin with aspartate 
does not mimic phosphorylation of this residue  
• Neurogranin exerts its effect on calcium saturation of CaM through a mechanism 
that is concentration dependent such that it drives it in a kinetically unfavorable 
direction.This result is relevant when you consider that phosphorylation of 
neurogranin by PKC prevents its interaction with CaM and hence reduces the 
functionally relevant concentration of neurogranin. 
 
98 
 
Future experiments would involve studying the effect of neurogranin on calcium 
interaction with calmodulin following low-frequency stimulations that result in long-term 
depression and high-frequency stimulations that result in long-term potentiation. This would 
require simulations in MATLAB that measure concentrations of calcium saturated CaM  
following calcium influx after a high-frequency stimulation or a low-frequency stimulation.  
Another issue to study would be the effect of phosphorylation of neurogranin on calcium 
interaction with CaM in a systematic way. To do this, currently known experimental values 
would be used to obtain optimal parameters. Using the optimal parameters, a model for 
phosphorylated neurogranin interaction with CaM would be built and the effect of high-
frequency and low-frequency stimulations would be studied.  
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